Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

Completed · Phase 4

Conditions studied: Hypertension

In brief

This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.

Key facts

Study ID

NCT00136851

Run by

Novartis Pharmaceuticals

People needed

259

Starts

2004-12-01

Expected to finish

2005-07-01

Last updated by the study team

2011-11-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of severe hypertension

You may not qualify if…

• Diastolic blood pressure (DBP) < 60 mm Hg
• Serum potassium < 3.5 or > 5.5 mEq/L in the absence of all potassium supplements
• Refractory hypertension defined as systolic blood pressure (SBP) ≥ 180 mmHg and/or DBP ≥ 110 mmHg and unresponsive to triple-drug regimens
• Other protocol-defined exclusion criteria may apply.

Where it is running

• Novartis Pharmaceuticals — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.